References and notes
- Farrington , G.K. , Kumar , A. and Wedler , F.C. 1985 . J. Med. Chem. , 28 : 1668
- Kafarski , P. , Lejczak , B. , Mastalerz , P. , Dus , D. and Radzikowski , C. 1985 . J. Med. Chem. , 28 : 1555
- Swyryd , E.A. , Seaver , S.S. and Stark , G.R. 1974 . J. Biol. Chem. , 249 : 6945
- Johnson , R.K. , Inowye , T. , Goldin , A. and Stark , G.R. 1976 . Cancer Res. , 36 : 2720 Weber, G. New Engl. J. Med. 1977, 296, 486
- Gleissner , B. , Wadler , S. , Hilgenfeld , R. , Schwartz , S. , Thiel , E. and Kreuser , E.D. 1994 . Ann. Oncol. , 5 abst. 442
- Ardalan , B. , Donofrio , K. , Livingstone , A. , Reddy , R. , Richman , S. , Sridhar , K.S. , Benedetto , P. , Morrell , L. , Miller , C.L. and Feun , L. 1995 . Proc. Amer. Soc. Clin. Oncol. , 14 abst. 558
- Hageboutros , A. , Hudes , G.R. , Brennan , J. , Green , F. , Hoffman , J. , Lacreta , F.P. , Colofiore , J. , Martin , D.S. , Ozols , R.F. and O'Dwyer , P.J. 1996 . Cancer Chemother. Pharmacol. , 37 : 229
- Shipkowitz , N.L. , Bower , R.R. , Appel , R.N. , Nordeen , C.W. , Overb , L.R. , Roderick , W.R. , Schleicher , J.B. and VON Esch , A.M. 1973 . Appl. Microbiol. , 26 : 264
- Wyde , P.R. , Moore , D.K. , Pimentel , D.M. and Blough , H.A. 1995 . Antivir. Res. , 27 : 59
- Blough , H.A. World Patent . 18762 . 1993 .
- Parsons , J.L. and Dubicki , H. US Patent . 4154759 . 1979 .
- Parsons , J.L. US Patent . 4178306 . 1980 .
- Schultz , R.J. and Starks , F.W. US Patent . 4215070 . 1981 .
- Henklein , P. , Gloede , J. , Gross , H. , Tschiersch , B. , Klose , A. , Winterfeld , G. , Steinke , W. and Niedrich , H. German Patent . 272092 . 1990 .
- Stiebitz , B. , Moegelin , W. , Balszuweit , A. and Issleib , K. German Patent . 286589 . 1991 .
- Goodson , J.J. , Wharton , C.J. and Wrigglesworth , R. 1981 . J.C.S. Perkin Tans. , 1 : 2721
- Montero , J.-L. and Imbach , J.-L. 1982 . Eur. J. Med. Chem. , 17 : 97
- Kafarski , P. and Soroka , M. 1982 . Synthesis , : 219
- Gigot , D. and Penninckx , M. 1984 . J. Pharm. Sci. , 73 : 275
- Tschiersch , B. 1988 . Pharmazie , 43 : 434
- The exception to this is ref. 6e.
- For example see ref. 1, 6e, 7a-c.
- This is opposed to the instability of alternative acid labile trimethylsilyl esters protection groups employed throughout the methodology of Stiebitz et al.6e whereupon purification by distillation or anhydrous chromatography became obligatory.
- McKenna , C.E. , Higa , M.T. , Cheung , N.H. and McKenna , M.-C. 1977 . Tetrahedron Lett. , 18 : 155
- McKenna , C.E. and Schmidhauser , J. 1979 . J.C.S. Chem. Comm. , : 739
- Salomon , C.J. and Breuer , E. 1995 . Tetrahedron Lett. , 36 : 6759
- Chakravarty , P.K. , Combs , P. , Roth , A. and Greenlee , W.J. 1987 . Tetrahedron Lett. , 28 : 611
- Demaine , D.A. , Smith , S. and Barraclough , P. 1992 . Synthesis , : 1065
- Following results from a kinetic study, the reaction was left for 6h at rt. The mixture was then concentrated, hydrolysed and lyophilysed, and resulting composition analysed by 1H NMR and reverse phase HPLC analysis.